• Users Online: 168
  • Print this page
  • Email this page

  Download for Citation Managers


A multicenter, double-blind, randomized phase III trial of ramucirumab plus docetaxel versus placebo plus docetaxel for treatment of Stage IV non-small cell lung cancer after disease progression on or after platinum-based therapy (REVEL): An Indian patient subgroup analysis
Prabhash Kumar, Doval D C, Rangarajan Bharath, Somani Naresh, Pruthi Aarohan, Dyachkova Yulia, Puri Tarun

Year : 2021 | Volume:  4 | Issue Number:  4 | Page: 634-641

Click here to read this article

Select type of program  for download
EndNote format (Mac & Win)
- Download
Reference Manager
Ris format (Win only)
- Download
Ris format (Win only)
- Download
Medlars Format - Download
RefWorks Format
RefWorks format (Mac & Win)
- Download
BibTex Format
BibTex format (Mac & Win)
- Download